CTRI/2024/07/069714Not yet recruitingUnknown
Establishing biochip-based cell free DNA repair assay for cancer treatment outcome prediction. - NI
Trial Snapshot
- Phase
- Unknown
- Status
- Not yet recruiting
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
Inclusion Criteria
- •1. Diagnosed with cervical cancer.
- •2. Planned to undergo chemo-radiotherapy.
- •3. Age over 18 years old.
- •4. Able to give informed consent.
Exclusion Criteria
- •1. prior cancer surgery
- •2. secondary cancer
- •3. metastasis
- •4. non-conventional treatment
Investigators
Similar Trials
Not yet recruiting
Not Applicable
Cell-free DNA as a new, minimally invasive and sensitive biomarker for early detection of allograft rejection after heart transplantatiocardiac surgeryheart disease10019280NL-OMON45738Erasmus MC, Universitair Medisch Centrum Rotterdam60
Recruiting
Not Applicable
Study of usefulness of a new advanced diagnostic test to find out the causative organism in eye infection after surgeryCTRI/2011/04/001685Aravind Eye Hospital50
Completed
Not Applicable
Development of a Cell Free DNA Assay as a Biomarker for Predicting Early Non-response to Therapy in Metastatic CancerMetastatic Colorectal CancerMetastatic Non-Small Cell Lung CarcinomaMetastatic Breast CancerNCT03892096Cadex Genomics130
Recruiting
Not Applicable
Establishment of a bio- and DNA bank with register in patients with cystic fibrosis.E84Cystic fibrosisDRKS00031784niversitätsklinikum Heidelberg3,000
Recruiting
Not Applicable
Biomarker study using cell-free DNA from patients with advanced breast canceradvanced breast cancerJPRN-UMIN000012881Kinki University Faculty of Medicine100